JENNIFER LUCATERO: Open Payments
NPI 1659808376 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 56 payments from 11 companies in 2025. Trend: 2023 $2,824 · 2024 $1,843 · 2025 $1,094
Food & beverage: $994Education: $100
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 14 | $257 |
| Amgen Inc. | 15 | $254 |
| ABBVIE INC. | 14 | $173 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $100 |
| GENZYME CORPORATION | 2 | $97 |
| Novartis Pharmaceuticals Corporation | 3 | $77 |
| Incyte Corporation | 3 | $68 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $14 |
Products named: OTEZLA, ADBRY, SKYRIZI, DUPIXENT, OPZELURA, COSENTYX, ANZUPGO, RINVOQ.
Industry payments across CA — which companies pay providers there.
